Visiopharm
Healthcare Software · Denmark · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Agern Allé 24, Havreholm, Capital Region...Phone Number
+45 88202088Website
www.visiopharm.comRevenue
$16.2 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Visiopharm
Visiopharm is a leading provider of AI-driven precision pathology software designed for research and diagnostics. Their products, including the Phenoplex and Discovery platforms, offer advanced tissue image analysis solutions that enhance accuracy and reproducibility in pathology. Targeting researchers and healthcare professionals, Visiopharm supports the development of next-generation therapies and diagnostic decision-making through innovative software and integration workflows. With a commitment to quality and cutting-edge technology, Visiopharm aims to address the evolving challenges in tissue analysis.Explore more
Visiopharm Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Visiopharm your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Visiopharm has new funding data
Product Launch: Get notified when Visiopharm launches new products
Check out if Visiopharm is spiking on competitors!
Earning: See what the market has to say on Visiopharm recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Visiopharm
Click to see if Visiopharm had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check if Visiopharm has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Visiopharm, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Visiopharm
Find 2 more new buyers
Company Profile Activity
Activity Insights
Visiopharm is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Visiopharm is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Visiopharm.
Visiopharm Tech Stack
A closer look at the technologies used by Visiopharm
See more technologies
Most Recent Scoops
Event
Events, Clinical Operations, Field Marketing, Healthcare Technology, Patient Experience
Event
Product Marketing, Events, Research & Development, Bioengineering, Medical Research, Clinical Operations, Healthcare Technology
Partnership
Integration, Partnership, Automation, Machine Learning, Digital Technology
New Hire
Executive Move
Visiopharm News & Media
CND Life Sciences Partners with Visiopharm on Novel AI-Tool to Detect and Quantify Pathological Alpha-Synuclein in Cutaneous Nerves
CND's Biomarker Testing Services Utilizing Groundbreaking NerValence™ System Unveiled at the AD/PD™ 2024 Parkinson's and Alzheimer's Disease Conference SCOTTSDALE, Ariz.., March 5, 2024 /PRNewswire/ -- CND Life Sciences (CND), a medical technology company pioneering the development of...ADDING MULTIMEDIA Visiopharm and Boston Cell Standards Announce Partnership to Develop Joint IHC Technology for Magnani-Taylor Regulatory Proposal
COPENHAGEN, Denmark & BOSTON--(BUSINESS WIRE)-- #biotech--Visiopharm and Boston Cell Standards today announced a partnership to develop a joint technology solution that enables labs to meet key provisions of regulatory changes proposed in a groundbreaking editorial recently published in Archives of Pathology & Laboratory Medicine. In a July 2023 Archives online editorial, Dr. Barbarajean Magnani and Dr. Clive Taylor proposed that clinical immunohistochemistry (IHC) quality assurance requirementsVisiopharm and Boston Cell Standards Announce Partnership to Develop Joint IHC Technology for Magnani-Taylor Regulatory Proposal
COPENHAGEN, Denmark & BOSTON--(BUSINESS WIRE)-- #biotech--Visiopharm and Boston Cell Standards today announced a partnership to develop a joint technology solution that enables labs to meet key provisions of regulatory changes proposed in a groundbreaking editorial recently published in Archives of Pathology & Laboratory Medicine. In a July 2023 Archives online editorial, Dr. Barbarajean Magnani and Dr. Clive Taylor proposed that clinical immunohistochemistry (IHC) quality assurance requirementsPaige and Visiopharm Work Together to Deliver Advanced AI Cancer Diagnostic Support Through the Paige Platform
NEW YORK--(BUSINESS WIRE)--Paige, a global leader in end-to-end digital pathology solutions and clinical AI applications to assist in diagnosing cancer, today announced it is working with Visiopharm, an artificial intelligence (AI)-driven precision pathology software provider, to bring a wider range of AI products to doctors and patients. Visiopharm’s AI applications will be deployed and natively integrated into the Paige Platform to be accessed through FullFolio™, Paige’s AI-powered clinical w
Read more news
Top Healthcare Software Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Visiopharm
Sign Up For FreeTo access detailed company insights
Visiopharm is a leading provider of AI-driven precision pathology software designed for research and diagnostics. Their products, including the Phenoplex and Discovery platforms, offer advanced tissue image analysis solutions that enhance accuracy and reproducibility in pathology. Targeting researchers and healthcare professionals, Visiopharm suppo... Read More
